Viewing StudyNCT00045110



Ignite Creation Date: 2024-05-05 @ 11:28 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00045110
Status: COMPLETED
Last Update Posted: 2017-08-17
First Post: 2002-09-06

Brief Title: Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-08
Start Date Type: None
Primary Completion Date: 2010-12
Primary Completion Date Type: ACTUAL
Completion Date: 2010-12
Completion Date Type: ACTUAL
First Submit Date: 2002-09-06
First Submit QC Date: January 26 2003
Study First Post Date: 2003-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2017-07-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-07-14
Last Update Post Date: 2017-08-17
Last Update Post Date Type: ACTUAL